Search

everythinglearnresearchcommunity

for

Search:↓

Combining finasteride and black soybean extract better protects hair cells from damage and may treat hair loss effectively with fewer side effects.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

Physical activity, height, and smoking affect prostate cancer risk.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Negative pressure treatment improved skin thickness, blood vessel growth, and hair growth.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

A 7-year-old boy with a brain tumor developed early puberty, which was successfully treated with medication.

Obesity is linked to more severe lower urinary tract symptoms.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Prostasin has two roles in skin: one for normal skin development without needing activation, and another for proper hair growth that requires activation.

LGF injections may improve early Peyronie's disease by reducing penile curvature and plaque size.

Stress worsens Tourette symptoms by increasing allopregnanolone levels.

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

Human scalp hair follicles have PGE2 and its receptors, which might affect hair growth.

The report expanded knowledge of MBTPS1-related disorders by identifying new symptoms.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

Finasteride may cause lasting sexual side effects, but more research is needed.

A point mutation in the androgen receptor gene causes complete androgen insensitivity.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Peripheral treatments showed some improvement in sexual dysfunction, but central symptoms remain challenging.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Reduced AR gene methylation may cause early pubic hair growth in girls.